Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: A 24-month follow-up study

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 11, 2002, Pages 1237-1243

  Mantzaris, Gerassimos J ^a,b   Petraki, Kalliopi ^a   Archavlis, Emmanuel ^a   Amberiadis, Pericles ^a   Christoforidis, Panagiotis ^a   Kourtessas, Demetrius ^a   Chiotakakou, Efterpi ^a   Triantafyllou, George ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Amoxicillin; Bismuth triple therapy; Clarithromycin; Duodenal ulcer; Helicobacter pylori; Omeprazole; Quadruple therapy

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CAMPYLOBACTER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DUODENUM ULCER; DYSPEPSIA; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK FACTOR; SIDE EFFECT; STOMACH BIOPSY; SYMPTOMATOLOGY; ULCER HEALING; UREA BREATH TEST;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; TETRACYCLINE; WOUND HEALING;

EID: 20244374505     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200211000-00012     Document Type: Article

References (36)

1. Borody TJ, Cole P, Noonan S, Morgan A, Lenne J, Hyland L, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151:431-435.
2. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, Collins BJ. Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow up. Lancet 1994; 343:258-260.
3. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, Malaty HM. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric or duodenal ulcer: A randomized, controlled study. Ann Intern Med 1992; 116:705-708.
4. Mantzaris GJ, Hatzis A, Tamvacologos G, Petraki Kal, Spiliades Ch, Triadaphyllou G. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers healing and long-term relapse rates. Dig Dis Sci 1993; 38:1132-1136.
5. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102:493-496.
6. Cutler A, Shubert T. Patients factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993; 88:505-509.
7. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7:835-840.
8. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdorffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 Study. Helicobacter 1996; 1:138-144.
9. Jaup BH, Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90:943-945.
10. Wurzer H, Rodrigo L, Stamler D, Archambault A, Rokkas T, Skandalis N, et al. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. Aliment Pharmacol Ther 1997; 11:943-952.
11. Laheij RJF, van Rossum LGM, Jansen JBMJ, Straatman H, Verbeek ALM. Evaluation of treatment regimens to cure Helicobacter pylori infection: A meta-analysis. Aliment Pharmacol Ther 1999; 13:857-864.
12. Borody TJ, Andrews P, Fracchia G, Brandl S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995; 37:477-481.
13. De Boer WA. How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients - A personal viewpoint. J Clin Gastroenterol 1996; 22:313-316.
14. De Boer WA, Tytgat GNJ. 90% Cure: Which anti-Helicobacter therapy can achieve this treatment goal? Am J Gastroenterol 1995; 90:1381-1382.
15. De Boer WA, Driessen WM, Jansz AR, Tytgat GN. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: Results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995; 7:1189-1194.
16. De Boer WA, Driessen WM, Potters VP, Tytgat GN. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994; 89:1993-1997.
17. De Boer WA, Driessen WMM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9:633-638.
18. Hosking SW, Ling TK, Yung MY, Cheng A, Chung SC, Leung JW, Li AK. Randomized controlled trial of short-term treatment to eradicate H. pylori in patients with duodenal ulcers. BMJ 1992; 305:502-504.
19. Borody TJ, Shortis NP, Chongnan J, Reyes E, O'Shea JE. Eradication failure (EF) after H. pylori treatment - Further therapies. Gastroenterology 1996; 110:A67.
20. Tjivras M, Balatsos V, Tsirantonaki M, Scandalis N, Archimandritis A. High eradication rate of Helicobacter pylori using a four-drug regimen in patients previously treated unsuccessfully. Clin Ther 1995; 19:906-912.
21. Gisbert JP, Gisbert JL, Marcos S, Gravalos RG, Carpio D, Pajares JM. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: Omeprazole, bismuth, tetracycline and metronidazole vs ranitidine bismuth citrate, tetracycline and metronidazole. Aliment Pharmacol Ther 1999; 13:1311-1316.
22. Lee JM, Breslin NP, Hyde DK, Buckley MJ, O'Morain CA. Treatment options for Helicobacter pylon infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharmacol Ther 1999; 13:489-496.
23. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The Updated Sydney System. Am J Surg Pathol 1996; 20:1161-1181.
24. Kearney DJ, Brousal A. Treatment of Helicobacter pylori infection in clinical practice in the United States. Results from 224 patients. Dig Dis Sci 2000; 45:265-271.
25. Yang JC, Kuo YN, Wang TH. Optimal 'rescue' therapy for Helicobacter pylori infection after failure of PPI-based triple therapies. Gut 2001; 49(Suppl 11):A86.
26. De Boer WA, van Etten RJXM, van de Wouw BAM, Schneeberger PM, van Oijen AHAM, Jansen JBMJ. Bismuth-based quadruple therapy for Helicobacter pylori - A single triple capsule plus lansoprazole. Aliment Pharmacol Ther 2000; 14:85-89.
27. Results of a multicentre European Survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. Eur J Microbiol Infect Dis 1992; 11:777-781.
28. Phull PS, Griffiths AE, Jacyna MR. One-week treatment for Helicobacter pylori infection: A randomized study of quadruple therapy versus triple therapy. J Antimicrob Chemother 1995; 36:1085-1088.
29. Gisbert JP, Hermida C, Pajares JM. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating Helicobacter pylon infection in peptic ulcer and in non-ulcer dyspepsia? Gut 2001; 49(Suppl 11):A88.
30. De Boer WA, van Etten RJXM, Schade RWB, Ouwehand ME, Schneeberger PM, Tytgat GNJ. 4-Day lansoprazole quadruple therapy: A highly effective cure for Helicobacter pylori infection. Am J Gastroenterol 1996; 91:1778-1782.
31. De Boer WA, van Etten RJ, Schade RW, Ouwehand ME, Schneeberger PM, van Unnik AJ, Tytgat GN. One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11:109-112.
32. Kung NN, Sung JJ, Yuen NW, Ng PW, Wong KC, Chung EC, et al. Anti-Helicobacter pylori treatment in bleeding ulcers: Randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Am J Gastroenterol 1997; 92:438-441.
33. Kamada T, Haruma K, Komoto K, Mihara M, Chen X, Yoshihara M, et al. Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin and clarithromycin. Helicobacter 1999; 4:204-210.
34. Georgopoulos SD, Ladas SD, Karatapanis S, Mentis A, Spiliadi C, Artikis V, Raptis SA. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin and clarithromycin. Dig Dis Sci 2000; 45:63-67.
35. Miehlke S, Bayerdorffer E, Lehn N, Mannes GA, Hochter W, Weingart J, et al. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7:975-978.
36. Archimandritis A, Balatsos V, Delis V, Manika Z, Skaandalis N. 'Reappearance' of Helicobacter pylori after eradication: Implications on duodenal ulcer recurrence: A prospective 6 year study. J Clin Gastroenterol 1999; 28:345-347.